US Omega-3 Supplement Firm Changes Claims On Amarin Challenge, But Not Label Or Company Name

Fish-Oil Based Drug Marketer's Latest Challenge To Omega-3 Claims Is NAD Review

National Advertising Division, in rare review of an Rx drug firm’s challenge of supplement ad claims, reported Innovix Pharma pulled health claims for OmegaVia brand supplements challenged by Amarin. Innovix prevailed in defending its labeling as accurate and its name as not false advertising.

• Source: Alamy

More from Compliance

More from Policy & Regulation